{"id":"https://openalex.org/W2980211863","doi":"https://doi.org/10.1182/blood.v128.22.2087.2087","title":"ABL Tyrosine Kinase Plays an Important Role in Mechanisms Involved in Genomic Instability in Multiple Myeloma","display_name":"ABL Tyrosine Kinase Plays an Important Role in Mechanisms Involved in Genomic Instability in Multiple Myeloma","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2980211863","doi":"https://doi.org/10.1182/blood.v128.22.2087.2087","mag":"2980211863"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.2087.2087","doi":"https://doi.org/10.1182/blood.v128.22.2087.2087","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.2087.2087","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103420970","display_name":"Subodh Kumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Subodh Kumar","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051370438","display_name":"Purushothama Nanjappa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Purushothama Nanjappa","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112389374","display_name":"Srikanth Talluri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Srikanth Talluri","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063099799","display_name":"Masood A. Shammas","orcid":"https://orcid.org/0000-0002-8932-6829","observed_orcids":["https://orcid.org/0000-0002-8932-6829"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Masood A Shammas","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2801671727","display_name":"VA Boston Healthcare System","ror":"https://ror.org/04v00sg98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I2801671727","https://openalex.org/I4210095851"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C Munshi","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","VA Boston Healthcare System, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"raw_affiliation_string":"VA Boston Healthcare System, Boston, MA","institution_ids":["https://openalex.org/I2801671727"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5051370438","https://openalex.org/A5103420970","https://openalex.org/A5112389374"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31009827,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"128","issue":"22","first_page":"2087","last_page":"2087"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5425000190734863,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.5425000190734863,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.4259999990463257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9279999732971191},{"id":"https://openalex.org/keywords/abl-tyrosine-kinase","display_name":"Abl tyrosine kinase","score":0.7369999885559082},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.871999979019165},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.9819999933242798},{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.8240000009536743},{"id":"https://openalex.org/keywords/bcr-abl1","display_name":"BCR-ABL1","score":0.8349999785423279},{"id":"https://openalex.org/keywords/dexamethasone-resistance","display_name":"dexamethasone resistance","score":0.8550000190734863},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.8460000157356262},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.7950000166893005},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.6159999966621399},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.574999988079071},{"id":"https://openalex.org/keywords/abl-kinase-inhibitors","display_name":"ABL kinase inhibitors","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C2779012473","wikidata":"https://www.wikidata.org/wiki/Q3235015","display_name":"RAD51","level":4,"score":0.8389862775802612},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.8317432999610901},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.8205986022949219},{"id":"https://openalex.org/C134935766","wikidata":"https://www.wikidata.org/wiki/Q210538","display_name":"DNA repair","level":3,"score":0.5904383659362793},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.5423733592033386},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5423638820648193},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.5194820165634155},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.5094690918922424},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4824562668800354},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.48022112250328064},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4344606101512909},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4211839735507965},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.40078577399253845},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.28703033924102783},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.22197213768959045},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.20694991946220398}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.2087.2087","doi":"https://doi.org/10.1182/blood.v128.22.2087.2087","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.2087.2087","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388900750","https://openalex.org/W3094645769","https://openalex.org/W2980699639","https://openalex.org/W2581763939","https://openalex.org/W2048888997","https://openalex.org/W3176076427","https://openalex.org/W2591224296","https://openalex.org/W2559622157","https://openalex.org/W2979816083","https://openalex.org/W2594634994"],"abstract_inverted_index":{"Abstract":[0],"Homologous":[1],"recombination":[2,61],"(HR)":[3],"is":[4,29,52,399],"a":[5,24,39,181,202,347],"DNA":[6,17,33,64,253],"repair":[7,34],"mechanism":[8,35,102,428],"that":[9,82,103,133,190,338,407],"uses":[10],"extensive":[11],"sequence":[12],"homology":[13],"in":[14,42,94,113,175,195,201,212,277,328,346,367,385,415,418],"the":[15,30,43,101,164,172,235,264,278,286,318,329,375,426],"participating":[16],"molecules":[18],"for":[19,282,441],"an":[20,119,412],"accurate":[21],"repair.":[22],"In":[23,402],"normal":[25],"cellular":[26],"environment,":[27],"HR":[28,51,84,109,193,210,246,341,357,398],"most":[31],"precise":[32],"and":[36,48,60,89,110,161,188,216,223,245,285,365,381,395,420,432],"therefore":[37],"has":[38,130],"unique":[40],"role":[41,414],"maintenance":[44],"of":[45,62,91,108,125,151,171,185,231,243,260,266,280,288,293,320,331,340,350,356,363,377,397,429,435,448],"genomic":[46,63,87,111,127,322,416,430,437],"integrity":[47],"stability.":[49],"Normally":[50],"tightly":[53],"regulated,":[54],"however,":[55],"as":[56,115,117,144,146,255,307],"it":[57,70,191],"involves":[58],"incision":[59],"fragments,":[65],"if":[66],"dysregulated":[67],"or":[68],"dysfunctional,":[69],"can":[71],"also":[72,249],"be":[73],"deleterious.":[74],"Consistent":[75],"with":[76,251,439],"this":[77,289],"view,":[78],"we":[79,97,334,352,404],"have":[80,98,178,335,405],"shown":[81,132],"elevated":[83],"activity":[85,194,211,247],"mediates":[86,155],"instability":[88,112,417,431],"development":[90],"drug":[92],"resistance":[93,345],"MM.":[95,368],"Here":[96],"now":[99],"investigated":[100,353],"may":[104,360],"contribute":[105],"to":[106,122,163,166,228,309,450],"dysregulation":[107],"MM,":[114],"well":[116,145],"evaluated":[118,179,299],"agent":[120],"able":[121],"decrease":[123],"acquisition":[124,319,434],"new":[126,294,311,321,436],"changes.":[128],"It":[129],"been":[131],"Abl":[134,186,408],"kinase":[135,160,187,410],"regulates":[136],"recombinase":[137],"RAD51":[138,152,232,239,244],"by":[139,220,257,326,358],"affecting":[140],"its":[141,156,421],"expression,":[142],"stability":[143],"phosphorylation":[147,230,236],"at":[148,233,315],"Y315.":[149],"Phosphorylation":[150],"(at":[153,370],"Y315)":[154],"dissociation":[157],"from":[158],"BCR-ABL1":[159],"migration":[162],"nucleus":[165],"form":[167],"nuclear":[168],"foci,":[169],"one":[170],"initial":[173],"steps":[174],"HR.":[176],"We":[177],"nilotinib,":[180,424],"small":[182],"molecule":[183],"inhibitor":[184],"observed":[189,393,406],"inhibited":[192,209,325],"all":[196],"MM":[197,218,271],"cell":[198],"lines":[199],"tested,":[200],"dose-dependent":[203],"manner.":[204],"At":[205],"5":[206],"\u00b5M,":[207],"nilotinib":[208,267,281,359],"MM1S,":[213],"RPMI":[214,386],"8226":[215,387],"U266":[217],"cells":[219,274,306],"64%,":[221],"78%":[222],"80%,":[224],"respectively.":[225],"Nilotinib":[226,369],"led":[227],"reduced":[229,252,258],"Y315,":[234],"which":[237],"affects":[238],"migration.":[240],"Nilotinib-mediated":[241],"inhibition":[242,355,396,422],"was":[248,298,324],"associated":[250],"breaks,":[254],"indicated":[256],"levels":[259],"g-H2AX.":[261],"To":[262],"determine":[263],"impact":[265,287],"on":[268,291],"genome":[269],"stability,":[270],"(RPMI":[272],"8226)":[273],"were":[275],"cultured":[276],"presence":[279,330],"three":[283],"weeks":[284],"treatment":[290],"appearance":[292],"copy":[295,312],"number":[296,313],"changes":[297,323,438],"using":[300,423],"SNP":[301],"arrays.":[302],"Using":[303],"day":[304],"0":[305],"baseline":[308],"identify":[310],"events":[314],"3":[316],"weeks,":[317],"50%":[327],"nilotinib.":[332],"As":[333],"previously":[336],"reported":[337],"induction":[339],"helps":[342],"develop":[343],"dexamethasone":[344,366,382],"short":[348],"period":[349],"time,":[351],"whether":[354],"improve":[361],"efficacy":[362,376],"melphalan":[364,378],"2.5":[371],"\u00b5M)":[372],"significantly":[373],"increased":[374],"(10":[379,383],"\u00b5M);":[380],"nM)":[384],"cells.":[388],"The":[389],"relation":[390],"between":[391],"these":[392],"effects":[394],"being":[400],"investigated.":[401],"conclusion,":[403],"tyrosine":[409],"plays":[411],"important":[413],"myeloma":[419],"suppresses":[425],"underlying":[427],"reduces":[433],"potential":[440],"clinical":[442],"application.":[443],"Disclosures":[444],"No":[445],"relevant":[446],"conflicts":[447],"interest":[449],"declare.":[451]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-10-18T00:00:00"}